...
首页> 外文期刊>Tissue antigens. >NKG2D ligands: unconventional MHC class I-like molecules exploited by viruses and cancer.
【24h】

NKG2D ligands: unconventional MHC class I-like molecules exploited by viruses and cancer.

机译:NKG2D配体:被病毒和癌症利用的非常规MHC I类分子。

获取原文
获取原文并翻译 | 示例
           

摘要

Our best teachers in revealing the importance of immune pathways are viruses and cancers that have subverted the most prominent pathways to escape from immune recognition. Viruses and cancer impair antigen presentation by classical MHC class I to escape adaptive immunity. The activating receptor NKG2D and its MHC class I-like ligands are other recently defined innate and adaptive immune pathways exploited by viruses and cancer. This review discusses recent advances in the understanding of how NKG2D, expressed on innate immune cells including natural killer cells, gammadelta+ T cells and macrophages, and adaptive immune cells such as CD8+ T cells, recognize stress-induced, MHC class I-like, self-ligands. Moreover, we describe how viruses and cancer have developed strategies to evade this recognition pathway.
机译:在揭示免疫途径重要性方面,我们最好的老师是病毒和癌症,它们颠覆了最主要的途径以逃避免疫识别。病毒和癌症会破坏I类经典MHC的抗原呈递,从而逃避适应性免疫。激活受体NKG2D及其MHC I类样配体是病毒和癌症利用的其他最近定义的先天性和适应性免疫途径。这篇综述讨论了在先天免疫细胞(包括自然杀伤细胞,γ+ T细胞和巨噬细胞)以及适应性免疫细胞(例如CD8 + T细胞)上表达的NKG2D如何识别应激诱导的I类MHC自我感觉的最新进展-配体。此外,我们描述了病毒和癌症如何发展出逃避这种识别途径的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号